| Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with a single Phe508del allele PG Middleton, MA Mall, P Dřevínek, LC Lands, EF McKone, D Polineni, ... New England Journal of Medicine 381 (19), 1809-1819, 2019 | 1601 | 2019 |
| SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 J Braun, L Loyal, M Frentsch, D Wendisch, P Georg, F Kurth, ... Nature 587 (7833), 270-274, 2020 | 1235 | 2020 |
| Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice M Mall, BR Grubb, JR Harkema, WK O'Neal, RC Boucher Nature medicine 10 (5), 487-493, 2004 | 1096 | 2004 |
| Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind … HGM Heijerman, EF McKone, DG Downey, E Van Braeckel, SM Rowe, ... The Lancet 394 (10212), 1940-1948, 2019 | 1038 | 2019 |
| Electrolyte transport in the mammalian colon: mechanisms and implications for disease K Kunzelmann, M Mall Physiological reviews 82 (1), 245-289, 2002 | 821 | 2002 |
| The future of cystic fibrosis care: a global perspective SC Bell, MA Mall, H Gutierrez, M Macek, S Madge, JC Davies, PR Burgel, ... The Lancet Respiratory Medicine 8 (1), 65-124, 2020 | 809 | 2020 |
| VX-445–tezacaftor–ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles D Keating, G Marigowda, L Burr, C Daines, MA Mall, EF McKone, ... New england journal of medicine 379 (17), 1612-1620, 2018 | 645 | 2018 |
| VX-659–tezacaftor–ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles JC Davies, SM Moskowitz, C Brown, A Horsley, MA Mall, EF McKone, ... New england journal of medicine 379 (17), 1599-1611, 2018 | 345 | 2018 |
| Characterization of wild-type and ΔF508 cystic fibrosis transmembrane regulator in human respiratory epithelia SM Kreda, M Mall, A Mengos, L Rochelle, J Yankaskas, JR Riordan, ... Molecular biology of the cell 16 (5), 2154-2167, 2005 | 316 | 2005 |
| Innate immunity in cystic fibrosis lung disease D Hartl, A Gaggar, E Bruscia, A Hector, V Marcos, A Jung, C Greene, ... Journal of Cystic Fibrosis 11 (5), 363-382, 2012 | 310 | 2012 |
| Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models MA Mall Journal of aerosol medicine and pulmonary drug delivery 21 (1), 13-24, 2008 | 306 | 2008 |
| Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children J Loske, J Röhmel, S Lukassen, S Stricker, VG Magalhães, J Liebig, ... Nature biotechnology 40 (3), 319-324, 2022 | 295 | 2022 |
| CFTR: cystic fibrosis and beyond MA Mall, D Hartl European Respiratory Journal 44 (4), 1042-1054, 2014 | 294 | 2014 |
| Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease MO Wielpütz, M Puderbach, A Kopp-Schneider, M Stahl, E Fritzsching, ... American journal of respiratory and critical care medicine 189 (8), 956-965, 2014 | 290 | 2014 |
| CXCR2 mediates NADPH oxidase–independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation V Marcos, Z Zhou, AÖ Yildirim, A Bohla, A Hector, L Vitkov, ... Nature medicine 16 (9), 1018-1023, 2010 | 268 | 2010 |
| The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways. M Mall, M Bleich, R Greger, R Schreiber, K Kunzelmann The Journal of clinical investigation 102 (1), 15-21, 1998 | 257 | 1998 |
| Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination L Loyal, J Braun, L Henze, B Kruse, M Dingeldey, U Reimer, F Kern, ... Science 374 (6564), eabh1823, 2021 | 254 | 2021 |
| Morphologic and functional scoring of cystic fibrosis lung disease using MRI M Eichinger, DE Optazaite, A Kopp-Schneider, C Hintze, J Biederer, ... European journal of radiology 81 (6), 1321-1329, 2012 | 221 | 2012 |
| Development of Chronic Bronchitis and Emphysema in β-Epithelial Na+ Channel–Overexpressing Mice MA Mall, JR Harkema, JB Trojanek, D Treis, A Livraghi, S Schubert, ... American journal of respiratory and critical care medicine 177 (7), 730-742, 2008 | 214 | 2008 |
| Comparison of lung clearance index and magnetic resonance imaging for assessment of lung disease in children with cystic fibrosis M Stahl, MO Wielpütz, SY Graeber, C Joachim, O Sommerburg, ... American journal of respiratory and critical care medicine 195 (3), 349-359, 2017 | 210 | 2017 |
Oliver EickelbergProfessor of Medicine, University of Pittsburgh Medical Center在 pitt.edu 的电子邮件经过验证
